Data on this website

This website contains clinical data published under the European Medicines Agency (EMA) policy on the publication of clinical data. The clinical data have been submitted by pharmaceutical companies to support their marketing applications for human medicines under the centralised procedure and have been assessed by the Committee for Human Medicinal Products (CHMP).

EMA is the first regulatory authority worldwide to provide such broad access to clinical data.

For more information on the clinical data on this website, see Clinical data available.

For more information on EMA and its policy on the publication of clinical data, see the EMA corporate website.

Latest news

08/06/17: User survey

EMA has launched a survey to collect feedback from users of this website. It should take less than 10 minutes to complete. User feedback will help EMA to make improvements to the website and to further develop its transparency policies. Start the survey (click on the "questionnaire" tab).

Latest clinical data published

Halaven (ERIBULIN) published 22 June 2017

OPDIVO (NIVOLUMAB) published 21 June 2017

OPDIVO (NIVOLUMAB) published 21 June 2017

Bortezomib Hospira (BORTEZOMIB) published 12 June 2017

Alprolix (EFTRENONACOG ALFA) published 2 June 2017

Rasagiline Mylan (RASAGILINE) published 2 June 2017

EndolucinBeta (LUTETIUM (177 LU) CHLORIDE) published 1 June 2017

Pemetrexed Fresenius Kabi (PEMETREXED) published 18 May 2017

Giotrif (AFATINIB) published 18 May 2017

TAGRISSO (OSIMERTINIB) published 5 May 2017